SCHEMBL25829322

SCHEMBL25829322

CC(C)(C)OC(=O)Nc1c(F)c(F)cc(F)c1C=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 1/20 0.39
▸ CA1 P00915 2/20 0.37
▸ CA12 O43570 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ CYP17A1 P05093 2/20 0.35
▸ SYK P43405 1/20 0.35
▸ LCK P06239 2/20 0.33
▸ CA2 P00918 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.32
▸ AAK1 Q2M2I8 2/20 0.32
▸ KCNQ4 P56696 1/20 0.32
▸ KCNQ5 Q9NR82 1/20 0.32
▸ TRPA1 O75762 1/20 0.32
▸ HDAC3 O15379 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ LMNA P02545 2/20 0.32
▸ HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31124321 0.86 ATR (0.41) ATRCA1CA12CA9CYP17A1
SCHEMBL18106503 0.81 CA12 (0.42) CA1CA12CA9CYP17A1SYK
SCHEMBL25829865 0.80 ATR (0.41) ATRCA1CA12CA9CYP17A1
SCHEMBL29955382 0.80 CYP17A1 (0.42) ATRCA1CA12CA9CYP17A1
SCHEMBL25863102 0.78 ATR (0.36) ATRCA1CA12CA9CYP17A1
SCHEMBL26429672 0.78 ATR (0.41) ATRCA1CA12CA9CYP17A1
SCHEMBL28895299 0.76 CA12 (0.44) CA1CA12CA9CYP17A1SYK
SCHEMBL3126895 0.75 ATR (0.43) ATRCA1CA12CA9CYP17A1
SCHEMBL30937750 0.75 HSP90AA1 (0.40) ATRCA1CA12CA9CYP17A1
SCHEMBL25829765 0.75 ATR (0.37) ATRCA1CA12CA9CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023137007-A1 PROCESSES FOR THE PREPARATION OF 4,6,7-TRIFLUORO-1H-INDOLE-2-CARBOXYLIC ACID ENANTA PHARMACEUTICALS, INC. (US) 2023-07-20 — — WO disclosed
Send feedback